Skip to Content
<< Back
Quality Systems, Inc. Reports Fiscal 2014 First Quarter Results
July 25, 2013 at 5:00 AM EDT

Lead Generation Increases 172 Percent Year-over-Year;
Pipeline Jumps Six Percent to $150.1 Million Quarter-over-Quarter

IRVINE, Calif.--(BUSINESS WIRE)-- Quality Systems, Inc. (NASDAQ:QSII) announced today results for its fiscal 2014 first quarter ended June 30, 2013.

The Company reported revenues of $109.5 million for the first quarter ended June 30, 2013, a decrease of seven percent when compared with $118.3 million for the 2013 first quarter. Net income for the fiscal 2014 first quarter was $12.9 million, a decrease of 16 percent versus net income of $15.5 million for the first quarter of fiscal 2013. Fully diluted earnings per share for the fiscal 2014 first quarter was $0.22, a decline of 15 percent from $0.26 reported in the first quarter of the last fiscal year.

During the quarter, the Company saw considerable advancement in lead generation, which grew 172 percent year-over-year. Additionally, Quality Systems is seeing significant growth in its sales pipeline for the first time in several quarters, which jumped to $150.1 million, a six percent improvement versus the prior quarter. These two key metrics, along with a reduction in total operating expenses, are signs that the restructuring efforts the Company implemented in late fiscal 2013 -- which included consolidation of its sales and marketing efforts, cross selling of services and solutions as well as the centralization of shared services -- are beginning to show positive momentum. Revenue from the Company's Revenue Cycle Management (RCM) and Electronic Data Interface (EDI) services grew 11 percent and 21 percent, respectively, in the fiscal 2014 first quarter compared with the same period last year, as clients continue to recognize the benefits of such services amid changing healthcare models and healthcare reform.

"Our management team is greatly encouraged that our restructuring plan is beginning to bear fruit. The bottom line is that our leads are up, our pipeline is up and our operating expenses are down," explained Steven T. Plochocki, Quality Systems' President and Chief Executive Officer.

"As the healthcare information technology sector continues to rapidly evolve and new models arise, we play a key role in helping our clients adapt. Quality Systems is now the only company to have achieved Stage 2 Meaningful Use (MU) certification for physicians, dentists and hospitals. In fact, the Company ranks among the top four for MU attestations for physicians, and is one of only four organizations in the top 12 for attestations for both the inpatient and ambulatory markets. Moreover, according to CMS, in the first quarter of this calendar year, NextGen Healthcare ranked number one in terms of improvement for new physicians reaching attestation, and also ranked number one in client retention rate, at 87 percent. We are leading the way in the marketplace by assisting our clients in reaching important industry milestones necessary to their success. Our efforts in this area continue to be a priority for our entire organization," Plochocki concluded.

Quality Systems also announced that its Board of Directors declared a quarterly cash dividend of Seventeen and One-Half Cents ($0.175) per share on the Company's outstanding shares of Common Stock, payable to shareholders of record as of September 13, 2013 with an anticipated distribution date of October 4, 2013. The $0.175 per share cash dividend is pursuant to the Company's current policy to pay a regular quarterly dividend on the Company's outstanding shares of Common Stock, subject to further Board review and approval, and establishment of record and distribution dates by the Board prior to the declaration and payment of each such quarterly dividend.

Quality Systems will host a conference call to discuss its fiscal 2014 first quarter results on Thursday, July 25, 2013 at 10:00 AM ET (7:00 AM PT). All participants should dial 1-866-900-9499 at least ten minutes prior to the start of the call and reference conference ID # 21310368. International callers should dial 1-937-502-2136. To hear a live Web simulcast or to listen to the archived webcast following completion of the call, please visit the company website at, click on the "Investors" tab, then select "Conference Calls," to access the link to the call. To listen to a telephone replay of the conference call, please dial 800-585-8367 or 404-537-3406 and enter conference ID # 21310368. The replay will be available from approximately 1:00 PM ET on Thursday, July 25, 2013, through 11:59 PM ET on Thursday, August 1, 2013.

A transcript of the conference call will be made available on the Company's website at

About Quality Systems, Inc.

Irvine, Calif.-based Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. Visit and for additional information.


This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue, net income and earnings per share). Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements are set forth in Part I, Item A of our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2013, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; and general economic conditions. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of a fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.


This news release contains certain non-GAAP (Generally Accepted Accounting Principles) financial measures which are provided only as supplemental information. Investors should consider these non-GAAP financial measures only in conjunction with the comparable GAAP financial measures. These non-GAAP measures are not in accordance with or a substitute for, U.S. GAAP. Pursuant to the requirements of Regulation G, the Company has provided a reconciliation of non-GAAP financial measures to the most directly comparable financial measure in the accompanying financial tables. Other companies may calculate non-GAAP measures differently than Quality Systems, which limits comparability between companies.

The Company believes that its presentation of non-GAAP measures, such as Days Sales Outstanding ("DSO"), provide useful supplemental information to investors and management regarding the Company's financial condition and results. The Company calculates DSO as follows: net revenue for the quarter is annualized (multiplied by four) and then divided by 365 days to yield an average daily sales amount. The balance of accounts receivable, net of any reserves for bad debts, is then divided by that average daily sales amount resulting in the DSO.



Three Months Ended June 30,
2013   2012
Software and hardware $ 15,972 $ 25,844
Implementation and training services   6,575     12,046  
System sales 22,547 37,890
Maintenance 38,608 38,568
Electronic data interchange services 16,692 13,823
Revenue cycle management and related services 16,015 14,401
Other services   15,667     13,614  
Maintenance, EDI, RCM and other services   86,982     80,406  
Total revenues   109,529     118,296  
Cost of revenue:
Software and hardware 4,934 5,771
Implementation and training services   7,134     9,145  
Total cost of system sales 12,068 14,916
Maintenance 5,302 4,811
Electronic data interchange services 10,796 9,248
Revenue cycle management and related services 11,401 10,870
Other services   8,505     8,550  
Total cost of maintenance, EDI, RCM and other services   36,004     33,479  
Total cost of revenue   48,072     48,395  
Gross profit 61,457 69,901
Operating expenses:
Selling, general and administrative 35,096 36,681
Research and development costs 5,614 8,576
Amortization of acquired intangible assets   1,194     1,137  
Total operating expenses   41,904     46,394  
Income from operations 19,553 23,507
Interest income, net 31 35
Other expense, net   (254 )   (213 )
Income before provision for income taxes 19,330 23,329
Provision for income taxes   6,385     7,832  
Net income $ 12,945   $ 15,497  
Net income per share:
Basic $ 0.22 $ 0.26
Diluted $ 0.22 $ 0.26
Weighted average shares outstanding:
Basic 59,559 59,281
Diluted 59,572 59,388
Dividends declared per common share $ 0.175 $ 0.175


June 30 March 31,
2013 2013
Current assets:
Cash and cash equivalents $ 118,212 $ 105,999
Restricted cash 3,647 5,488
Marketable securities 11,814 12,012
Accounts receivable, net 138,949 148,257
Inventories 983 710
Deferred income tax assets, net 12,140 12,140
Other current assets   10,561     12,720  
Total current assets 296,306 297,326
Equipment and improvements, net 21,825 21,887
Capitalized software costs, net 44,402 39,781
Intangibles, net 25,684 27,550
Goodwill 45,761 45,761
Other assets   10,843     10,750  
Total assets $ 444,821   $ 443,055  
Current liabilities:
Accounts payable $ 7,440 $ 11,501
Deferred revenue 62,725 65,207
Accrued compensation and related benefits 12,073 11,915
Income taxes payable 5,550 1,480
Dividends payable 10,426 10,418
Other current liabilities   26,477     26,508  
Total current liabilities 124,691 127,029
Deferred revenue, net of current 1,285 1,219
Deferred compensation 3,950 3,809
Other noncurrent liabilities   4,791     3,949  
Total liabilities 134,717 136,006
Commitments and contingencies
Shareholders' equity:
Common stock

$0.01 par value; authorized 100,000 shares; issued and
outstanding 59,588 and 59,543 shares at June 30, 2013
and March 31, 2013, respectively

596 595
Additional paid-in capital 180,450 179,743
Accumulated other comprehensive loss (184 ) (11 )
Retained earnings   129,242     126,722  
Total shareholders' equity   310,104     307,049  
Total liabilities and shareholders' equity $ 444,821   $ 443,055  


June 30, 2013
Quarterly Revenue $ 109,529
Times four (4)


Equals Annualized Revenue 438,116
Divided by 365 days


Equals Average Daily Revenue


$ 1,200
Net Accounts Receivable $ 138,949
Divided by Average Daily Revenue


Equals Days Sales Outstanding



Quality Systems, Inc.
Susan J. Lewis, 303-804-0494
Paul Holt, CFO, 949-255-2600

Source: Quality Systems, Inc.

News Provided by Acquire Media